In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS 

No. 14-933V 

(Not to be published) 

* * * * * * * * * * * * * * * * * * * * * * * * * 

SANDRA WHITE, *

 * Filed: January 14, 2016 

 Petitioner, * 

 * Decision by Stipulation; Damages; 

 v. * Influenza (“Flu”) Vaccine; Transverse 

 * Myelitis (“TM”); Attorney’s Fees

 * and Costs 

SECRETARY OF HEALTH AND * 

HUMAN SERVICES, * 

 *

 Respondent. *

 *

* * * * * * * * * * * * * * * * * * * * * * * * * 

Reginald Anthony Jason Greene, Greene Legal Group, Atlanta, GA, for Petitioner.

Althea Davis, U.S. Dep’t of Justice, Washington, DC, for Respondent. 

DECISION AWARDING DAMAGES AND ATTORNEY’S FEES1

On October 2, 2014, Petitioner Sandra White filed an action seeking compensation under 

the National Vaccine Injury Compensation Program (the “Vaccine Program”)

2

. Petitioner alleges 

that she suffered transverse myelitis as a result of receiving an influenza (“flu”) vaccine on October 

3, 2012. 

Respondent denies that Ms. White’s transverse myelitis or any related medical problems 

were caused by her receipt of the flu vaccine. Nonetheless both parties, while maintaining their 

 

1

 Because this decision contains a reasoned explanation for my action in this case, I will post this decision on the 

United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-

347, § 205, 116 Stat. 2899, 2913 (Dec. 17, 2012) (current version at 44 U.S.C. §3501 (2014)). As provided by 42 

U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the posted decision’s inclusion of certain kinds of 

confidential information. Specifically, under Vaccine Rule 18(b), each party has 14 days within which to request 

redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance 

and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would 

constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision will be 

available to the public. (Id.) 

2

 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury 

Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C.A. ' 300aa-10-' 300aa-34 (2012).
2

above-stated positions, agreed in a stipulation filed January 13, 2016, (ECF No. 22) [hereinafter 

“Stip.”] that the issues before them can be settled, and that a decision should be entered awarding 

Petitioner compensation. 

I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation 

is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth 

therein. 

The stipulation awards: 

a) A lump sum of $140,000.00, in the form of a check payable to petitioner. This 

amount represents compensation for all damages that would be available under 

42 U.S.C. §300aa-15(a). 

Stip. ¶ 8(a). 

 The parties filed an additional stipulation on January 13, 2016 (ECF No. 26) [hereinafter 

“Stip. for Fees”] that they had reached the following agreement with respect to attorney’s fees and 

costs: 

b) A lump sum of $26,809.99 in the form of a check payable jointly to petitioner 

and petitioner’s attorney, Reginald A. Greene, for [all] attorneys’ fees and costs 

available under 42 U.S.C. § 300aa-15(e). 

Stip. for Fees ¶ 8(b). 

In addition, and in compliance with General Order No. 9, Petitioner has represented that she did 

not incur any reimbursable costs in proceeding on this petition. 

I approve a Vaccine Program award of $140,000.00 in the form of a check to be made 

payable to Petitioner. In addition, I also approve of the attorney’s fees and costs in the amount of 

$26,809.99 in the form of a check to be made payable to Petitioner and Petitioner’s counsel. In the 

absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is 

directed to enter judgment herewith.3

IT IS SO ORDERED. 

 

 /s/ Brian H. Corcoran

 Brian H. Corcoran 

 Special Master 

 

3

 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly (or separately) filing notice(s) 

renouncing their right to seek review.